10-Q Filing

ENVERIC BIOSCIENCES, INC. CIK: 890821 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001477932-13-005130`
Period End Date	20130930
Filing Date	20131106
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	spzr-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 46 Income Statement 28 Cash Flow Statement 24

Balance Sheet 46 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.15K	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$684.00	USD	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Cash and Cash Equivalents	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Preferred stock, authorized shares	`PreferredStockSharesAuthorized`	1.00M	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, issued shares	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Other Current Assets	`OtherAssetsCurrent`	$4.22K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$4.90K	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$5.60K	USD	Point-in-time
Preferred stock, outstanding shares	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Total Assets	`Assets`	$5.60K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total Assets	`Assets`	$4.90K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, authorized shares	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Common stock, issued shares	`CommonStockSharesIssued`	12.14M	shares	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$9.62K	USD	Point-in-time
Accounts Payable and Accrued Liabilities	`AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent`	$17.67K	USD	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Common stock, outstanding shares	`CommonStockSharesOutstanding`	12.14M	shares	Point-in-time
Loans from Stockholders	`DueToOfficersOrStockholdersCurrent`	$8.00K	USD	Point-in-time
Loans from Stockholders	`DueToOfficersOrStockholdersCurrent`	$28.50K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$38.12K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$25.67K	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares, $.01 par value, 1,000,000 shares authorized, none issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 12,142,000 shares issued and outstanding	`CommonStockValue`	$121.42K	USD	Point-in-time
Common shares, $.01 par value, 300,000,000 shares authorized, 12,142,000 shares issued and outstanding	`CommonStockValue`	$121.42K	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Additional Paid-In Capital	`AdditionalPaidInCapitalCommonStock`	$47.25M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.39M	USD	Point-in-time
Accumulated Deficit	`RetainedEarningsAccumulatedDeficit`	$-47.41M	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-20.07K	USD	Point-in-time
Total Stockholders' Equity (Deficit)	`StockholdersEquity`	$-33.21K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$4.90K	USD	Point-in-time
Total Liabilities and Stockholders' Equity (Deficit)	`LiabilitiesAndStockholdersEquity`	$5.60K	USD	Point-in-time

Income Statement 28 line items

Line Item	Tag	Value	Unit	Period
General and Administrative	`GeneralAndAdministrativeExpense`	$13.15K	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$4.56K	USD	1 Quarter
General and Administrative	`GeneralAndAdministrativeExpense`	$12.69K	USD	3 Qtrs
General and Administrative	`GeneralAndAdministrativeExpense`	$4.57K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-12.69K	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-4.56K	USD	1 Quarter
Operating Loss	`OperatingIncomeLoss`	$-13.15K	USD	3 Qtrs
Operating Loss	`OperatingIncomeLoss`	$-4.57K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-13.15K	USD	3 Qtrs
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.56K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-4.57K	USD	1 Quarter
Loss Before Income Taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-12.69K	USD	3 Qtrs
Income Taxes	`IncomeTaxExpenseBenefit`	$300.00	USD	3 Qtrs
Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Income Taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income Taxes	`IncomeTaxExpenseBenefit`	$300.00	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-12.99K	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-4.56K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.87K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-13.15K	USD	3 Qtrs
Basic and Diluted Earnings (Loss) Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Basic and Diluted Earnings (Loss) Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and Diluted Earnings (Loss) Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	3 Qtrs
Basic and Diluted Earnings (Loss) Per Share	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	3 Qtrs
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	1 Quarter
Weighted Average Shares Outstanding	`WeightedAverageNumberOfSharesOutstandingBasic`	12.14M	shares	3 Qtrs

Cash Flow Statement 24 line items

Line Item	Tag	Value	Unit	Period
Net Loss	`NetIncomeLoss`	$-12.99K	USD	3 Qtrs
Net Loss	`NetIncomeLoss`	$-4.56K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-4.87K	USD	1 Quarter
Net Loss	`NetIncomeLoss`	$-13.15K	USD	3 Qtrs
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.09K	USD	3 Qtrs
Accounts Payable and Accrued Liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-8.05K	USD	3 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.08K	USD	3 Qtrs
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivities`	$-21.20K	USD	3 Qtrs
Loans from Officers	`LoansFromOfficers`	$20.50K	USD	3 Qtrs
Loans from Officers	`LoansFromOfficers`	$5.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$5.00K	USD	3 Qtrs
Net Cash Provided by Financing Activities	`NetCashProvidedByUsedInFinancingActivities`	$20.50K	USD	3 Qtrs
Decrease in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-16.08K	USD	3 Qtrs
Decrease in Cash and Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-697.00	USD	3 Qtrs
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$2.15K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$684.00	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$2.15K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$684.00	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$1.38K	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$18.23K	USD	Point-in-time
Income Taxes	`IncomeTaxesPaid`	$300.00	USD	3 Qtrs
Income Taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.